申请人:ADRX INC
公开号:WO2018226992A1
公开(公告)日:2018-12-13
This invention relates to the field of tau aggregation inhibitors. More specifically, the invention relates to anti-amyloid therapeutics. More specifically, the invention provides pharmaceutical compositions and methods of treating aggregation associated conditions or diseases with certain peptides.